In this study, we found that interfering Foxp1 by siRNA reduced the expression of E2F1 and Rb, and promoted the expression of AR and β-catenin, suggesting that Foxp1 is a tumor suppressor gene in colon cancer. The gene discussed is RB1; the disease is malignant colon neoplasm.